- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06270069
Responsiveness and Minimal Important Change of Two Measures of Pain Intensity in People With Low Back Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is an observational study aimed at evaluating the responsiveness and minimal important change of two different graphical ways to assess pain intensity in people with low back pain.
Literature found out that low back pain intensity is commonly assessed by a numerical rating scale ranging from no pain to the worst imaginable pain, once presented to responders horizontally. A different way to assess pain intensity could be to answer a similar numerical rating scale if set vertically.
In Literature there are not studies which head-to-head evaluate the responsiveness and minimal important change of these two ways of assessing pain intensity due to low back pain.
Participants will also have to complete self-reported outcome measures of disability, catastrophizing, fear of movement and self-efficacy, and correlations among these tools and the above two different ways to evaluate pain intensity will be evaluated. Descriptive statistics will be presented by taking into account the socio-demographic characteristics of the sample under investigation.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Barbara Rocca, MSC
- Phone Number: 3333653393
- Email: info.ellis.bm@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Non specific low back pain
- Adult age
- Ability to understand the Italian language
Exclusion Criteria:
- Refuse to adhere to the study
- Definite causes of low back pain
- Central or peripheral neurological signs
- Systemic illness or psychiatric deficits
- Recent myocardial infarction, cerebrovascular events, or chronic lung or renal diseases
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NRS
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
|
Numerical Rating Scale; score 0-10 with higher estimates indicating higher levels of pain intensity (horizontal line)
|
Immediately before the rehab treatment starts and immediately after the intervention
|
Gauge of pain
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
|
Numerical Rating Scale; score -5/+5 with lower estimates indicating higher levels of pain intensity (vertical line)
|
Immediately before the rehab treatment starts and immediately after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ODI
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
|
Oswestry Disability Index; score 0-50 with higher scores representing greater restriction to activities.
|
Immediately before the rehab treatment starts and immediately after the intervention
|
PCS
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
|
Pain Catastrophizing Scale; score 0-52 with higher estimates showing higher catastrophizing
|
Immediately before the rehab treatment starts and immediately after the intervention
|
TSK
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
|
Tampa Scale of Kinesiophobia; score 13-52 with higher estimates showing higher fear of movement
|
Immediately before the rehab treatment starts and immediately after the intervention
|
PSEQ
Time Frame: Immediately before the rehab treatment starts and immediately after the intervention
|
Pain Self Efficacy Questionnaire; score 0-60 with higher estimates showing higher self-effficacy
|
Immediately before the rehab treatment starts and immediately after the intervention
|
GPE
Time Frame: Immediately after the intervention
|
Global Perceived Effect (how much did the treatment received help your pain?); score -3 (it worsen a lot the things)/+3 (it helped a lot)
|
Immediately after the intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Ache Laboratorios Farmaceuticos S.A.Unknown
-
Palmer College of ChiropracticDepartment of Health and Human ServicesCompletedChronic Low Back Pain | Subacute Low Back PainUnited States
-
Universität Duisburg-EssenSiemens-BetriebskrankenkasseCompletedChronic Low Back Pain | Recurrent Low Back Pain
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Apsen Farmaceutica S.A.CompletedLow Back Pain | Low Back Pain, Mechanical | Acute Low Back PainBrazil
Clinical Trials on Excercise-based therapy
-
Brigham and Women's HospitalRecruiting
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedPain | Fatigue | Chronic Fatigue Syndrome | Myalgic EncephalomyelitisNorway
-
Riphah International UniversityRecruitingPain | Flexibility | Iliotibial Band SyndromePakistan
-
Riphah International UniversityCompleted
-
Indonesia UniversityCompleted
-
University Hospital HeidelbergThe German Heart Foundation; Apple Inc.; Deutsches Zentrum für Herz-Kreislauf-Forschung... and other collaboratorsRecruiting
-
Cairo UniversityActive, not recruitingPeripheral Arterial DiseaseEgypt
-
Mansoura UniversityCompletedKnee Osteoarthriis and Oxidative StressEgypt
-
Najran UniversityCompletedHealthcare ProfessionalsSaudi Arabia